Clinical Investigation

Kidney International (1993) 44, 1101–1108; doi:10.1038/ki.1993.355

Autosomal dominant polycystic kidney disease in Toronto

Janet M Roscoe1, Jane E Brissenden1, E Alexander Williams1, Anne L Chery1 and Mel Silverman1

1Division of Nephrology, The Wellesley Hospital; Toronto Region Dialysis Registry, Multiple Organ Retrival and Exchange—Toronto Region; and Division of Nephrology, The Toronto Hospital, General Division, Toronto, Ontario, Canada

Correspondence: Janet M Roscoe MD, Suite 310, Elsie K. Jones Building, 160 Wellesley Street East, Toronto, Ontario M4Y 1J3, Canada.

Received 7 April 1993; Revised 6 July 1993; Accepted 6 July 1993.

Top

Abstract

Autosomal dominant polycystic kidney disease in Toronto. This study describes the Toronto, Ontario experience with autosomal dominant polycystic kidney disease (ADPKD). Patients were divided into three groups: Group 1, 19 families studied with genetic markers; Group 2, 80 pre-dialysis ADPKD patients followed by Toronto nephrologists in whom the incidence of non-renal complications and the mean age of onset of symptomatology is documented; Group 3, 4,449 individuals who entered end-stage renal failure (ESRF) in the Toronto region between the years 1981 and 1992, 320 with ADPKD and 4129 with other diseases. In this third group age of onset of ESRF, frequency, age and cause of death is compared between ADPKD and non-ADPKD. ADPKD caused by a gene different from that linked to chromosome 16 short-arm probes occurred at a frequency of between 8 and 17%. Incidence of hepatic cysts in ADPKD was similar to that of previous series, other organ involvement was underdiagnosed without deliberate screening, and incidence of symptomatic intracranial aneurysm was 1.25%. A 5% excess of patients with ADPKD died of cerebro-vascular accident. Years of survival after ESRF measured by life table analysis was significantly greater for ADPKD patients than for non-ADPKD patients. A high frequency of death due to infection still exists in ADPKD despite the reduction of invasive procedures in diagnosis and treatment, and despite the presumably improved recent methods of managing infection. The average age of onset of ESRF has been delayed by over six years, and average age of death of ADPKD patients at 63.9 years-old by 12.4 years since 1960.

Top

References

  1. Scientific Advisory Board of the National Kidney Foundation Workshop, September 16, 1988. Am J Kid Dis 8:85–87, 1989
  2. Iglesias CG, Torres VE, Offord KP, et al: Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota. Am J Kid Dis 2:630–639, 1983
  3. Hodgkinson KA, Kerzin-Storrar L, Watters EA, Harris R: Adult polycystic kidney disease: Knowledge, experience, and attitudes to prenatal diagnosis. J Med Genet 27:552–558, 1990
  4. Delaney VB, Alder S, Burns FJ, Licinia M, Segel DP, Fraley DS: Autosomal dominant polycystic kidney disease: Presentation, complication, and prognosis. Am J Kid Dis 5:104–111, 1985
  5. Wakabayashi T, Fujita S, Ohbora Y, Suyama T, Tamaki N, Matsumoto S: Polycystic kidney disease and intracranial aneurysms. J Neurosurg 58:488–491, 1983
  6. Ryu S-J: Intracranial hemorrhage in patients with polycystic kidney disease. Stroke 21:291–294, 1990 | PubMed | ISI | ChemPort |
  7. Chauveau D, Sirieix M-E, Schillinger F, Legendre C, Grünfeld J-P: Recurrent rupture of intracranial aneurysms in autosomal dominant polycystic kidney disease. Br Med J 301:966–967, 1990
  8. Torres VE, Wiebers DO, Forbes GS: Cranial computed tomography and magnetic resonance imaging in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1:84–90, 1990
  9. Fehlings MG, Gentili F: The association between polycystic kidney disease and cerebral aneurysms. Can J Neurol Sci 18:505–509, 1991
  10. Lozano AM, Leblanc R: Cerebral aneurysms and polycystic kidney disease: A critical review. Can J Neurol Sci 19:222–227, 1992
  11. Chapman AB, Rubinstein D, Hughes R, Stears JC, Earnest MP, Johnson AM, Gabow PA, Kaehny WD: Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 327:917–920, 1992
  12. Sekimoto M, Hayasaka S, Setogawa T, Shigeno K: Endogenous Escherichia coli endophthalmitis in a patient with autosomal-dominant-polycystic kidney disease. Ann Ophthalmol 23:458–459, 1991
  13. Riedasch G, Mohring K, Bihl H: Septische Komplikationen bei polyzystischer nierendegeneration. Helv chir acta 53:265–268, 1986
  14. Bretan PN, Price DC, McClure RD: Localization of abcess in adult polycystic kidney by indium-111 leukocyte scan. Urology XXXII(2): 169–171, 1988
  15. Dalgaard OZ: Bilateral polycystic disease of the kidneys. Acta Med Scand 156 (Suppl. 328):1–25, 1957
  16. Dalgaard OZ: Polycystic disease of the kidneys, in Disease of the Kidneys, edited by MB Strauss, LG Welt, Boston, Little, Brown & Co., 1963, pp 1223–1258
  17. Gabow PA: Autosomal dominant polycystic kidney disease—More than a renal disease. Am J Kid Dis XVI(5):403–413, 1990
  18. Gabow PA: Polycystic kidney disease: Clues to pathogenesis. Kidney Int 40:989–996, 1991 | PubMed | ChemPort |
  19. Gabow PA, Schrier RW: Pathophysiology of adult polycystic kidney disease. Adv Nephrol 18:19–32, 1989 | ChemPort |
  20. Gabow PA, Inklerman DW, Holmes JH: Polycystic kidney disease: Prospective analysis of nonazotemic patients and family members. Ann Intern Med 101:238–247, 1984 | PubMed | ISI | ChemPort |
  21. Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, Pearson PL, Weatherall DJ: A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature (Lond) 317:542–544, 1985
  22. Reeders ST, Breuning MH, Corney G, Jeremiah SJ, MeeraKhan P, Davies KE, Hopkinson DA, Pearson PL, Weatherall DJ: Two genetic markers closely linked to adult polycystic kidney disease on chromosome 16. Br Med J 292:851–853, 1986
  23. Reeders ST, Keith T, Green P, Germino GG, Barton NJ, Lehmann OJ, Brown VA, Phipps P, Morgan J, Bear JC, Parfrey P: Regional localization of the autosomal dominant polycystic kidney disease locus. Genomics 3:150–155, 1988
  24. Breuning MH, Snijdewint FGM, Brunner H, Verwest A, Ijdo JW, Saris JJ, Dauwerse JG, Blonden L, Keith T, Callen DF, Hyland VJ, Xiao GH, Scherer G, Higgs DR, Harris P, Bachner L, Reeders ST, Germino G, Pearson PL, van Ommen GJB: Map of 16 polymorphic loci on the short arm of chromosome 16 close to the polycystic kidney disease gene (PKD1.). J Med Genet 27:603–613, 1990 | PubMed | ChemPort |
  25. Somlo S, Germino GG, Wirth B, Weinstat-Saslow D, Barton N, Gillespie GAJ, Frischauf AM, Reeders ST: The molecular genetics of autosomal-dominant polycystic kidney disease of the PKD1 Type, in Polycystic Kidney Disease. Contrib Nephrol (vol 97), edited by MH Breuning, M Devoto,G Romeo, Basel, Karger, 1992, pp 101–109
  26. Kimberling WJ, Fain PR, Kenyon JB, Goldgar D, Sujansky E, Gabow PA: Linkage heterogeneity of autosomal dominant polycystic kidney disease. N Engl J Med 319:913–918, 1988 | ChemPort |
  27. Romeo G, Devoto M, Costa G, Roncuzzi L, Catizone L, Zucchelli P, Germino GG, Keith T, Weatherall DJ, Reeders ST: A second genetic locus for autosomal dominant polycystic kidney disease. Lancet 2:8–11, 1988 | Article | PubMed | ISI | ChemPort |
  28. Nørby S, Sørensen AWS, Boesen P: Non-allelic genetic heterogeneity of autosomal dominant polycystic kidney disease? in Genetics of Kidney Disorders, edited by C Bartsoces, Proceedings of Fifth International Clinical Genetics Seminar, New York: Alan R. Liss, 1989, pp 83–88
  29. Parfrey PS, Bear JC, Morgan J, Cramer BC: The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 323:1085–1090, 1990 | PubMed | ISI | ChemPort |
  30. Brissenden JE, Roscoe JM, Simpson NE, Silverman M: Linkage exclusion between the autosomal dominant polycystic kidney disease locus and chromosome 16 markers in a new family. J Am Soc Nephrol 2:913–919, 1991
  31. Morton NE: Sequential tests for linkage. Am J Hum Genet 7:277–317, 1955 | PubMed | ISI | ChemPort |
  32. Ott J: Estimation of the recombination fraction in human pedigrees. Efficient computation of the likelihood for human linkage studies. Am J Hum Genet 26:588–597, 1974 | PubMed | ISI | ChemPort |
  33. Hodge SE, Morton LA, Tideman S, Kidd KK, Spence MA: Age of onset correction available for linkage analysis (LIPED) [News and Comments]. Am J Hum Genet 31:761–762, 1979
  34. Bear JC, McManamon P, Morgan J, Payne RH, Lewis H, Gault MH, Churchill DN: Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: Data for genetic counselling. Am J Med Genet 18:45–53, 1984 | PubMed | ISI | ChemPort |
  35. Lathrop GM, Lalouel J-M, Julier C, Ott J: Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 81:3443–3446, 1984 | Article | PubMed | ChemPort |
  36. Lathrop GM, Lalouel JM, Julier C, Ott J: Multilocus linkage analysis in humans: Detection of linkage and estimation of recombination. Am J Hum Genet 37:482–498, 1985 | PubMed | ISI | ChemPort |
  37. SAS Institute Inc. SAS/STAT™ User's Guide. Release 6.03 Edition, Cary, SAS Institute Inc., (chapt 8) Introduction to Survival Analysis Procedure, pp 87–88; (chapt 21) The LIFEREG Procedure, pp 641–666; (chapt 19), The FREQ Procedure, pp 519–548; (chapt 33) The TTEST Procedure, pp 941–947; 1988
  38. de la Monte SM, Moore GW, Monk MA, Hutchins GM: Risk factors for the development and rupture of intracranial berry aneurysms. Am J Med 78:957–964, 1985
  39. Wiebers DO, Whisnant JP, Sundt TM Jr, O'Fallon M: The significance of unruptured intranial saccular aneurysms. J Neurosurg 66:23–29, 1987 | PubMed | ISI | ChemPort |
  40. Levey AS, Pauker SG, Kassirer JP: Occult intracranial aneurysms in polycystic kidney disease: When is cerebral angiography indicated? N Engl J Med 308:986–994, 1983
  41. McAlpine PJ, Shows TB, Boucheix C, Huebner M, Anderson WA: The 1991 catalog of mapped genes and report of the nomenclature committee. Cytogenet Cell Gen 58:5–102, 1991

Extra navigation

.
ADVERTISEMENT